Transdermal iontophoretic delivery of enoxacin from various liposome-encapsulated formulations

Zinner, 1989, Clinical overview of enoxacin, Clin. Pharmacokinet., 16, 59, 10.2165/00003088-198900161-00010 Sorgel, 1989, Pharmacokinetic disposition of quinolones in human body fluids and tissues, Clin. Pharmacokinet., 16, 5, 10.2165/00003088-198900161-00004 Schulz, 1997, Therapeutic and toxic blood concentrations of more than 500 drugs, Pharmazie, 52, 895 Fang, 1998, Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis, J. Control. Release, 54, 293, 10.1016/S0168-3659(98)00010-8 Ogiso, 1996, Mechanism for enhancement effect of lipid disperse system on percutaneous absorption, J. Pharm. Sci., 85, 57, 10.1021/js950178x Vulta, 1996, Transdermal iontophoretic delivery of enkephalin formulated in liposomes, J. Pharm. Sci., 85, 5, 10.1021/js950349y Lin, 1996, The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig’s eye, J. Pharm. Pharmacol., 48, 801, 10.1111/j.2042-7158.1996.tb03977.x Nakakura, 1996, Electrochemical stability of desmopressin acetate during iontophoresis, Chem. Pharm. Bull., 44, 1238, 10.1248/cpb.44.1238 Fang, 1997, Characterization and stability of various liposome-encapsulated enoxacin formulations, Chem. Pharm. Bull., 45, 1504, 10.1248/cpb.45.1504 Winterhalter, 1996, Liposomes in electric fields, 285 Winterhalter, 1987, Effect of voltage on pores in membranes, Phys. Rev., 36, 5874, 10.1103/PhysRevA.36.5874 Wilhelm, 1993, Kinetics of pore size during irreversible electrical breakdown of lipid bilayer membranes, Biophys. J., 64, 121, 10.1016/S0006-3495(93)81346-8 Touitou, 1994, Liposomes as carriers for topical and transdermal delivery, J. Pharm. Sci., 83, 1189, 10.1002/jps.2600830902 Vemuri, 1995, Preparation and characterization of liposomes as therapeutic delivery systems: a review, Pharm. Acta Helvet., 70, 95, 10.1016/0031-6865(95)00010-7 Blume, 1993, Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids, Int. J. Pharm., 99, 219, 10.1016/0378-5173(93)90364-L Suhonen, 1997, Transepidermal delivery of β-blocking agents: evaluation of enhancer effects using stratum corneum lipid liposomes, J. Control. Release, 43, 251, 10.1016/S0168-3659(96)01495-2 Fang, 1997, Transdermal iontophoresis of sodium nonivamide acetate; III: Combined effect of pretreatment by penetration enhancers, Int. J. Pharm., 149, 183, 10.1016/S0378-5173(97)04870-9 Kurosaki, 1991, Use of lipid disperse systems in transdermal delivery: comparative study of flufenamic acid permeation among rat abdominal skin, silicon rubber membrane and stratum corneum sheet isolated from hamster cheek pouch, Int. J. Pharm., 67, 1, 10.1016/0378-5173(91)90259-Q Yokomizo, 1996, Effect of phosphatidylcholine on the percutaneous penetration of drugs through the dorsal skin of guinea pigs in vitro; and analysis of the molecular mechanism, using attenuated total reflectance–fourier transform infrared (ATR–FTIR) spectroscopy, J. Control. Release, 42, 249, 10.1016/0168-3659(96)01458-7 Coderch, 1996, Percutaneous penetration of liposomes using the tape stripping technique, Int. J. Pharm., 139, 197, 10.1016/0378-5173(96)04620-0 Ogiso, 1997, Mechanism for enhancement effect of lipid disperse system on percutaneous absorption Part II, Int. J. Pharm., 152, 135, 10.1016/S0378-5173(97)04919-3 Schreier, 1994, Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery, J. Control. Release, 30, 1, 10.1016/0168-3659(94)90039-6 Rao, 1994, Enhancement of iontophoretic permeation of insulin across human cadaver skin, Pharmazie, 49, 538 Heit, 1994, Transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH): effect of repeated administration, Pharm. Res., 11, 1000, 10.1023/A:1018983303842 Burgess, 1996, Lipids as raw materials for pharmaceutical products: properties and characteristics, 5 Saarinen-Savolainen, 1997, Method for evaluating drug release from liposomes in sink conditions, Int. J. Pharm., 159, 27, 10.1016/S0378-5173(97)00264-0 Yoshida, 1993, Solute molecular size and transdermal iontophoresis across excised human skin, J. Control. Release, 25, 177, 10.1016/0168-3659(93)90077-I du Plessis, 1992, Topical delivery of liposomally encapsulated gamma-interferon, Antiviral Res., 18, 259, 10.1016/0166-3542(92)90059-E Needham, 1989, Electro-mechanical permeabilization of lipid vesicles, Biophys. J., 55, 1001, 10.1016/S0006-3495(89)82898-X Cevc, 1996, The skin: a pathway for the systemic treatment with patches and lipid-based agent carriers, Adv. Drug Deliv. Rev., 18, 349, 10.1016/0169-409X(95)00091-K Yu, 1996, Triamcinolone permeation from different liposome formulations through rat skin in vitro, Int. J. Pharm., 27, 1, 10.1016/0378-5173(95)04055-2 Weiner, 1989, Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model, Antimicrob. Agents Chemother., 33, 1217, 10.1128/AAC.33.8.1217